tirzepatide pregnancy safety data and Pregnancy: Safety, Risks & What to Do Pregnancy and Tirzepatide: Safety Facts

GLP-1 receptor agonists are a class of medications primarily prescribed for the management of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities

The results of the risk of bias assessment are summarized in the Table S8

Understanding the physiological changes after stopping tirzepatideincluding return of appetite, metabolic shifts, and potential cardiovascular risk factor worseningenables clinicians and patients to implement evidence-based maintenance strategies and determine when medical consultation is essential

No appointment required

Both are effective for weight loss, but Mounjaro (tirzepatide) has shown slightly greater average weight reduction in clinical trials compared to Wegovy (semaglutide)

Tirzepatide timing and other medications Tirzepatide slows gastric emptying